18,627 Shares of Option Care Health, Inc. $OPCH Bought by Choreo LLC

Choreo LLC purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 18,627 shares of the company’s stock, valued at approximately $419,000.

Other large investors have also recently made changes to their positions in the company. VestGen Advisors LLC purchased a new position in Option Care Health during the third quarter valued at $220,000. Leeward Investments LLC MA grew its position in shares of Option Care Health by 20.1% in the third quarter. Leeward Investments LLC MA now owns 848,059 shares of the company’s stock valued at $19,073,000 after purchasing an additional 142,007 shares in the last quarter. Sterling Capital Management LLC raised its stake in shares of Option Care Health by 361.7% in the third quarter. Sterling Capital Management LLC now owns 4,866 shares of the company’s stock valued at $109,000 after acquiring an additional 3,812 shares in the last quarter. James Investment Research Inc. boosted its stake in shares of Option Care Health by 53.6% during the third quarter. James Investment Research Inc. now owns 20,122 shares of the company’s stock worth $453,000 after buying an additional 7,025 shares during the period. Finally, Isthmus Partners LLC increased its stake in shares of Option Care Health by 37.9% during the 3rd quarter. Isthmus Partners LLC now owns 169,172 shares of the company’s stock worth $3,805,000 after purchasing an additional 46,518 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Price Performance

Shares of OPCH opened at $31.65 on Friday. The business’s 50 day moving average price is $27.30 and its two-hundred day moving average price is $26.37. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. Option Care Health, Inc. has a 52-week low of $18.01 and a 52-week high of $36.80. The firm has a market cap of $4.74 billion, a PE ratio of 20.06, a price-to-earnings-growth ratio of 1.93 and a beta of 0.47.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Wednesday, November 4th. The company reported $0.49 earnings per share for the quarter, meeting the consensus estimate of $0.49. The company had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.48 billion. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%. Option Care Health’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.45 earnings per share. On average, equities analysts anticipate that Option Care Health, Inc. will post 1.70 EPS for the current year.

Wall Street Analyst Weigh In

OPCH has been the topic of several recent analyst reports. Truist Financial set a $32.05 price target on Option Care Health in a research report on Wednesday, October 7th. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and increased their target price for the stock from $28.00 to $32.05 in a research report on Tuesday, October 6th. Weiss Ratings raised shares of Option Care Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, October 20th. Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. Finally, JPMorgan Chase & Co. cut Option Care Health from an “overweight” rating to a “neutral” rating and set a $33.00 price target on the stock. in a research note on Wednesday, October 7th. Two investment analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. According to MarketBeat.com, Option Care Health currently has a consensus rating of “Hold” and a consensus target price of $29.48.

Option Care Health Profile

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.